Immunoconjugates
Concept
Vocabulary Service
Overview
subject area of
-
A Bispecific Antifibrin-antiplatelet Urokinase Conjugate (BAAUC) Induces Enhanced Clot Lysis and Inhibits Platelet Aggregation Academic Article
-
Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases Academic Article
-
Antibody–drug conjugates in glioblastoma therapy: the right drugs to the right cells Academic Article
-
Characterising the phenotypic evolution of circulating tumour cells during treatment Academic Article
-
Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate Academic Article
-
Clinical comparison of radiolocalization of two monoclonal antibodies (mAbs) against the TAG-72 antigen Academic Article
-
Concurrent Binding of Anti-EphA3 Antibody and Ephrin-A5 Amplifies EphA3 Signaling and Downstream Responses: Potential as EphA3-Specific Tumor-Targeting Reagents Academic Article
-
Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma. Academic Article
-
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study Academic Article
-
Induction of Specific T-Cell Responses, Opsonizing Antibodies, and Protection against Plasmodium chabaudi adami Infection in Mice Vaccinated with Genomic Expression Libraries Expressed in Targeted and Secretory DNA Vectors Academic Article
-
Inhibition and Genetic Ablation of the B7/CD28 T-Cell Costimulation Axis Prevents Experimental Hypertension Academic Article
-
Internalization, Intracellular Trafficking, Biodistribution of Monoclonal Antibody 806: A Novel Anti-Epidermal Growth Factor Receptor Antibody Academic Article
-
Phase I Biodistribution and Pharmacokinetic Study of Lewis Y-Targeting Immunoconjugate CMD-193 in Patients with Advanced Epithelial Cancers Academic Article
-
Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma Academic Article
-
Platelet-targeted dual pathway antithrombotic inhibits thrombosis with preserved hemostasis Academic Article
-
Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma Academic Article
-
Specific Targeting, Biodistribution, and Lack of Immunogenicity of Chimeric Anti-GD3 Monoclonal Antibody KM871 in Patients With Metastatic Melanoma: Results of a Phase I Trial Academic Article
-
Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-GD3 ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts Academic Article
-
Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors Academic Article
-
Tumor Targeting by a Multivalent Single-Chain Fv (scFv) Anti-Lewis Y Antibody Construct Academic Article
-
Tumour cell surface antigen targeted therapies in B-cell lymphomas: Beyond rituximab Academic Article